| Study title | A Randomized, Double-Blind, Placebo-Controlled Clinical Trial To Evaluate The Efficacy Of Dupilumab (Anti-Il4ra) In Subjects With Eosinophilic Gastritis (DEGAS) |
| Disease or condition | Eosinophilic Gastritis |
| Study type | Interventional (Clinical Trial) |
| Intervention/treatment | Dupolumab or placebo |
| Phase | 2 |
| Study site | University of North Carolina at Chapel Hill |
| Study location | Chapel Hill |
| Principal investigator name and email | Evan Dellon, MD, MPH cedas@med.unc.edu |
| Study coordinator name and email | Wyatt Moorer, wwmoorer@email.unc.edu |
| Phone contact | (919) 843-4480 |
| Clinicaltrials.gov link | https://clinicaltrials.gov/ct2/show/NCT03678545 |